HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Rhea-AI Summary

Harmony Biosciences Holdings (Nasdaq: HRMY) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Jeffrey M. Dayno, M.D., President and CEO, will present at the conference on January 15, 2025, at 11:15 a.m. PT / 2:15 p.m. ET. Investors and interested parties can access the fireside chat webcast through Harmony's investor relations website.

News Market Reaction

-0.45%

1 alert

-0.45% News Effect

On the day this news was published, HRMY declined 0.45%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PLYMOUTH MEETING, Pa., Dec. 18, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Jeffrey M. Dayno, M.D., President and Chief Executive Officer, is scheduled to present at the conference on Wednesday, January 15, 2025, at 11:15 a.m. PT / 2:15 p.m. ET.

A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302334274.html

SOURCE Harmony Biosciences

FAQ

When is Harmony Biosciences (HRMY) presenting at the JP Morgan Healthcare Conference 2025?

Harmony Biosciences will present on Wednesday, January 15, 2025, at 11:15 a.m. PT / 2:15 p.m. ET.

How can investors watch Harmony Biosciences' (HRMY) JP Morgan Healthcare Conference presentation?

Investors can watch the webcast of the fireside chat through Harmony's investor relations website at https://ir.harmonybiosciences.com/.

Who will represent Harmony Biosciences (HRMY) at the 2025 JP Morgan Healthcare Conference?

Jeffrey M. Dayno, M.D., President and Chief Executive Officer of Harmony Biosciences, will represent the company at the conference.

Which healthcare conference will Harmony Biosciences (HRMY) attend in January 2025?

Harmony Biosciences will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.